Search results
13 results found
Making the most of genomics: supporting clinical research and careBlogThe UK House of Commons Science and Technology Committee has announced a new inquiry that will explore the antimicrobial potential of bacteriophages (phages), a topic explored by the PHG Foundation in our 2021 policy briefing on phage therapy.
Fragmentomics – the future of cfDNA testing?BlogOutlining the work of Prof. Dennis Lo and his team on the emerging science of fragmentomics.
Developing effective ctDNA testing services for lung cancerReportOur report outlines the most pressing issues affecting the implementation and provision of ctDNA testing services for lung cancer and describes the early experiences of some of the laboratories
Delivering improved access to genetic testing in epithelial ovarian cancerReportThis report describes the implementing a clinical genetics-coordinated service in our region to allow improved access to BRCA1/BRCA2 testing for epithelial ovarian cancer patients
Realising genomics in clinical practiceReportThe Realising Genomics report is intended to inform the ethical clinical implementation of these genomic technologies.
Next steps in the sequenceReportThe first comprehensive guide to the clinical impact WGS/NGS technologies,. With specific recommendations for prompt and effective adoption within the UK National Health Service (NHS).
Functional genomicsPolicy briefingAcross these two policy briefings, we outline what functional genomics is, the approaches used in this field and explore the potential impact of functional genomics on clinical medicine.
What is clinical utility?ExplainerEvidence of clinical utility is a key requirement of healthcare evaluation frameworks, however, demonstrating this is not straightforward.
Brokering the conversationCase studyThe 2020 Clinical genome analysis evidence review from PHG Foundation fed directly into strategic planning for the design and provision of clinical genetic services in Scotland